Flow Cytometry Market

Flow cytometers use lasers as light sources to produce scattered and fluorescent light signals, which are noticed by photodiodes or photomultiplier tubes and are transformed to electronic signals.

The Global Flow Cytometry Market valued at $3.5 billion (2021) is set to witness a significant growth rate of 8.9% in the next 5 years. High prevalence of targeted disease such as HIV/AIDS and cancer, increasing investments in R&D by market players, developments in instruments and reagents, and rising acceptance of flow cytometry techniques for research applications are some of the main factors driving the Global Flow Cytometry Market.

Progressions in flow cytometers and reagents to fuels the Flow Cytometry Market demand

Continuous advances in flow cytometry technology made it possible to create efficient, portable, and easy-to-use cell sorters and analyzers to deliver quick and precise results while also reducing turnaround times. Such developments tend to provide competitive edge to manufacturers and therefore, major players are continuously focusing on investing in research activities for new product development to strengthen their positions in this high growth market.

Here is a list of a few technological advancements:

• In April 2022, Becton, Dickinson and Company introduced a range of reagents for flow cytometry. Developed with dye technology and AI guidance, the BD Horizon RealYellow 586 Reagents offer improved data resolution to researchers and provide greater insights from samples compared to traditional fluorochromes
• In March 2022, Beckman Coulter Life Sciences launched CellMek SPS, a fully automated sample preparation system (SPS) that offers on-demand processing for a group of sample types, thereby expanding the capabilities of laboratories
• In August 2021, Becton, Dickinson and Company launched its benchtop cell analyzer “FACSymphony A1”, offering new capabilities to researchers in small as well as large labs by performing exploratory experiments without tying up freestanding cell analyzers
• In June 2021, Thermo Fisher Scientific launched the Invitrogen Attune CytPix Flow Cytometer, an imaging-enhanced flow cytometer that helps researchers collect high-performance fluorescent flow cytometry data and simultaneously capture high resolution brightfield images

Explore Premium Report on Flow Cytometry Market @ https://meditechinsights.com/flow-cytometry-market/

Growing investments and funding to develop novel technologies to boost adoption across applications

High growth of the flow cytometry market has attracted a lot of interest among market players and research institutes to invest in the R&D of novel technologies to boost the adoption of this technology for both research and clinical applications, as well as to co-develop advanced technologies.

Some of the investments and funding are listed below:

• In February 2022, The Conrad Prebys Foundation has awarded more than $1.17 million to La Jolla Institute for Immunology's (LJI) to support its Flow Cytometry Core and over $415,000 to advance infectious disease research at LJI. The funding is aimed at purchasing cutting-edge flow cytometry equipment for research activities related to cancers, COVID-19, and heart disease
• In December 2021, Accellix Inc. has raised $10 million investment from BroadOak Capital Partners to accelerate the development and manufacturing of tools and services for cell and gene therapy based on Accellix’s benchtop flow cytometry platform
• In August 2021, the Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $23 million to researchers at the University of Texas Health Science Center at San Antonio (UT Health San Antonio), out of which $3.6 million is intended to upgrade its flow cytometry center

Competitive Landscape Analysis of Flow Cytometry Market

The global flow cytometry market is marked by the presence of key players such as Becton, Dickinson and Company (US); Beckman Coulter, Inc. (acquired by Danaher Corporation, US); Bio-Rad Laboratories, Inc. (US); Thermo Fisher Scientific, Inc. (US); Miltenyi Biotec GmbH (Germany); Agilent Technologies, Inc. (US); Sony Group Corporation (Japan); and others.

For More Comprehensive Insights, Contact Us @ https://meditechinsights.com/contact-us/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

 Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com